Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …vaccine for breast cancer, which is difficult to treat due to the fact there are many types of breast cancer, and treatments that work well for some people might not… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 24 Aug 2022 Study findings could lead to new anti-cancer drugs …this not only in the test tube, but also in cultures with so-called triple-negative breast cancer cells. These are extremely difficult to treat – they usually hardly respond to therapies.”… August 24, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Startup Scout 15 Sep 2022 Adva Biotechnology is using artificial intelligence to manufacture cell therapies …to more treatments that save lives. “Behind all this, it’s a potential cancer treatment,” said Bercovich. “This is something that we speak about every now and then to not forget.”… September 15, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates …the development of drugs that mimic these natural protective mechanisms. Plus, substances derived from animals, such as snake venoms, can also lead to the development of therapeutics to treat diseases… October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 1 Jun 2023 Fighting obesity with gene therapy …mice through ex vivo gene therapy. The technique consists of implanting cells that have been manipulated and transformed in order to treat a disease. This is the first study to… June 1, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology …genes for self-replication derived from RNA viruses that are genetically programmed. Once they enter target cells, they translate the therapeutic protein they are encoding to treat the disease in the… October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Jul 2024 The future of inflammatory bowel disease treatment: what is on the horizon? …binds to α4β7, thus disabling its ability to bind to the receptor that takes the cells into the gut. Thanks to this inhibition, T cells can stay in the bloodstream… July 25, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 28 Jun 2024 Going nuclear: radiopharmaceuticals funding sees surge in 2024 …in detecting the target, enters the cancer cells. The radioactive compound then breaks down, releasing energy that damages cancer cells, as these cells are particularly sensitive to DNA damage that… June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 …carrying the target sequence. FAME (Function Addition to the Microbiome): With this modality, the vector carries a gene cassette that allows a bacterium to express a therapeutic function. Intellia Therapeutics… September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2023 Legend Biotech new drug application approved in China …two BCMA-targeting single domain antibodies designed to confer high avidity against human BCMA. Upon binding to BCMA-expressing cells, the CAR promotes T-cell activation, expansion, and elimination of target cells. In… January 3, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jun 2019 Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market …this, but in Kiadis’ therapy, the T cells that attack the patient are removed, allowing half-matched donors from the patient’s family to safely donate bone marrow. Currently at phase I,… June 3, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jul 2023 CytoMed Therapeutics receives US patent for CAR-Gamma Delta T-cell technology …T cells from a small amount of donor peripheral blood cells as well as the modification of the expanded γδ T cells to incorporate a chimeric antigen receptor (CAR) that… July 7, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email